Actual Medicinal Product (AMP) Acrivastine 8mg capsules (Brown & Burk UK Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products Benadryl Allergy Releif (McNeil Products) and Acrivastine 8mg capsules (Brown & Burk UK Ltd).

Generic
Acrivastine
Formulation
Acrivastine 8mg capsules
  • Acrivastine
    • Acrivastine 8mg capsules

      • Acrivastine 8mg capsules (Brown & Burk UK Ltd)



Related Formulations (1)

compatible_special_measures logo Acrivastine 8mg capsules